Skrivanek, Z., Berry, S., Berry, D., Chien, J., Geiger, M. J., Anderson, J. H., & Gaydos, B. (2012). Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society.
Citación estilo ChicagoSkrivanek, Zachary, Scott Berry, Don Berry, Jenny Chien, Mary Jane Geiger, James H. Anderson, and Brenda Gaydos. Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society, 2012.
Cita MLASkrivanek, Zachary, et al. Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations. Diabetes Technology Society, 2012.